The DOI matches its Crossref record; 323 of the 323 references it cites were found in a registry or an index.
Psychosis pathways converge via D2High dopamine receptors
Abstract
The objective of this review is to identify a target or biomarker of altered neurochemical sensitivity that is common to the many animal models of human psychoses associated with street drugs, brain injury, steroid use, birth injury, and gene alterations. Psychosis in humans can be caused by amphetamine, phencyclidine, steroids, ethanol, and brain lesions such as hippocampal, cortical, and entorhinal lesions. Strikingly, all of these drugs and lesions in rats lead to dopamine supersensitivity and increase the high-affinity states of dopamine D2 receptors, or D2High, by 200-400% in striata. Similar supersensitivity and D2High elevations occur in rats born by Caesarian section and in rats treated with corticosterone or antipsychotics such as reserpine, risperidone, haloperidol, olanzapine, quetiapine, and clozapine, with the latter two inducing elevated D2High states less than that caused by haloperidol or olanzapine. Mice born with gene knockouts of some possible schizophrenia susceptibility genes are dopamine supersensitive, and their striata reveal markedly elevated D2High states; suchgenes include dopamine-beta-hydroxylase, dopamine D4 receptors, G protein receptor kinase 6, tyrosine hydroxylase, catechol-O-methyltransferase, the trace amine-1 receptor, regulator of G protein signaling RGS9, and the RIIbeta form of cAMP-dependent protein kinase (PKA). Striata from mice that are not dopamine supersensitive did not reveal elevated D2High states; these include mice with knockouts of adenosine A2A receptors, glycogen synthase kinase GSK3beta, metabotropic glutamate receptor 5, dopamine D1 or D3 receptors, histamine H1, H2, or H3 receptors, and rats treated with ketanserin or aD1 antagonist. The evidence suggests that there are multiple pathways that convergetoelevate the D2High state in brain regions and that this elevation may elicit psychosis. This proposition is supported by the dopamine supersensitivity that is a common feature of schizophrenia and that also occurs in many types of genetically altered, drug-altered, and lesion-altered animals. Dopamine supersensitivity, in turn, correlates with D2High states. The finding that all antipsychotics, traditional and recent ones, act on D2High dopamine receptors further supports the proposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINSON, T., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,106
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Seeman, P. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,892
Self-citationFerguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Self-citationDe Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Disruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., Babulas, V. P., & Susser, E. S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.774 · Cited by 1,053
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · cited 1×
“Moreover, the D2 receptor is the common target for all antipsychotics, including both the traditional and the newer ones (Miyamoto et al., 2005; Seeman, 2001).”
BackgroundAn Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Self-citationDopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Self-citationPrenatal developmental disturbances in the limbic allocortex in schizophrenics
Jakob, H., & Beckmann, H. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249090 · Cited by 875
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412499 · Cited by 829
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 759
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W.-J., & Yan, Z. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Blackwood, D. H. R., Fordyce, A., Walker, M. T., St. Clair, D. M., Porteous, D. J., & Muir, W. J. (2001) · The American Journal of Human Genetics · doi:10.1086/321969 · Cited by 733
Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic
Zhou, Q.-Y., & Palmiter, R. D. (1995) · Cell · doi:10.1016/0092-8674(95)90145-0 · Cited by 731
Association within a family of a balanced autosomal translocation with major mental illness
St Clair, D., Blackwood, D., Muir, W., Walker, M., St Clair, D., Muir, W., Carothers, A., Spowart, G., Gosden, C., & Evans, H. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91520-k · Cited by 727
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
Seeman, P., Chau-Wong, M., Tedesco, J., & Wong, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4376 · Cited by 701
Self-citationLipska, B. K., Jaskiw, G. E., & Weinberger, D. R. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.44 · Cited by 697
Effects of Ketamine in Normal and Schizophrenic Volunteers
Lahti, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674
Mathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
Winterer, G., & Weinberger, D. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.002 · Cited by 600
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Le Moine, C., & Bloch, B. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903550308 · Cited by 575
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030718 · Cited by 574
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder
Segurado, R., Detera-Wadleigh, S. D., Levinson, D. F., Lewis, C. M., Gill, M., Nurnberger, J. I., Craddock, N., DePaulo, J. R., Baron, M., Gershon, E. S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376547 · Cited by 569
Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F., & Conquet, F. (2001) · Nature Neuroscience · doi:10.1038/nn0901-873 · Cited by 554
Longitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold, S. E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310043008 · Cited by 526
Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520
Location of a Major Susceptibility Locus for Familial Schizophrenia on Chromosome 1q21-q22
Brzustowicz, L. M., Hodgkinson, K. A., Chow, E. W. C., Honer, W. G., & Bassett, A. S. (2000) · Science · doi:10.1126/science.288.5466.678 · Cited by 516
DeLisi, L. E., Sakuma, M., Tew, W., Kushner, M., Hoff, A. L., & Grimson, R. (1997) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(97)00012-7 · Cited by 512
Hyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 499
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432926100 · Cited by 489
Hersch, S., Ciliax, B., Gutekunst, C., Rees, H., Heilman, C., Yung, K., Bolam, J., Ince, E., Yi, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05222.1995 · Cited by 483
Kapur, S., VanderSpek, S. C., Brownlee, B. A., & Nobrega, J. N. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046987 · Cited by 479
Phencyclidine-induced psychosis
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.9.1081 · Cited by 478
Wyatt, R. J., Alexander, R. C., Egan, M. F., & Kirch, D. G. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90034-5 · Cited by 477
Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine
Rubinstein, M., Phillips, T. J., Bunzow, J. R., Falzone, T. L., Dziewczapolski, G., Zhang, G., Fang, Y., Larson, J. L., McDougall, J. A., Chester, J. A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80365-7 · Cited by 471
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
Accili, D., Fishburn, C. S., Drago, J., Steiner, H., Lachowicz, J. E., Park, B. H., Gauda, E. B., Lee, E. J., Cool, M. H., Sibley, D. R., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1945 · Cited by 468
Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal
Lee, S. P., So, C. H., Rashid, A. J., Varghese, G., Cheng, R., Lança, A. J., O'Dowd, B. F., & George, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401923200 · Cited by 468
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459
Self-citationTalbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C.-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420425 · Cited by 455
Richfield, E. K., Penney, J. B., & Young, A. B. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90168-1 · Cited by 447
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446
Gold, S. J., Ni, Y. G., Dohlman, H. G., & Nestler, E. J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-08024.1997 · Cited by 434
Takahashi, N., Miner, L. L., Sora, I., Ujike, H., Revay, R. S., Kostic, V., Jackson-Lewis, V., Przedborski, S., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9938 · Cited by 429
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia
Egan, M. F., Straub, R. E., Goldberg, T. E., Yakub, I., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bertolino, A., Hyde, T. M., Shannon-Weickert, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405077101 · Cited by 416
MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders
Geuze, E., Vermetten, E., & Bremner, J. D. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001579 · Cited by 412
Regulators of G-Protein signalling as new central nervous system drug targets
Neubig, R. R., & Siderovski, D. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd747 · Cited by 403
Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity
Yao, W.-D., Gainetdinov, R. R., Arbuckle, M. I., Sotnikova, T. D., Cyr, M., Beaulieu, J.-M., Torres, G. E., Grant, S. G. N., & Caron, M. G. (2004) · Neuron · doi:10.1016/s0896-6273(04)00048-0 · Cited by 380
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376
Association and linkage analyses of RGS4 polymorphisms in schizophrenia
Chowdari, K. V. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.12.1373 · Cited by 368
SESACK, S. R., CARR, D. B., OMELCHENKO, N., & PINTO, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.066 · Cited by 367
Do we still believe in the dopamine hypothesis? New data bring new evidence
Abi-Dargham, A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004110 · Cited by 361
Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Diaz, M., & Braff, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1660 · Cited by 356
Dopamine supersensitivity correlates with D2Highstates, implying many paths to psychosis
Seeman, P., Weinshenker, D., Quirion, R., Srivastava, L. K., Bhardwaj, S. K., Grandy, D. K., Premont, R. T., Sotnikova, T. D., Boksa, P., El-Ghundi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409766102 · Cited by 352
Self-citationSchwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00015-9 · Cited by 344
Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 331
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Stimulant psychosis: systematic review
Curran, C., Byrappa, N., & McBride, A. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.3.196 · Cited by 318
Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317
SEEMAN, P. (1987) · Neuropsychopharmacology · doi:10.1016/0893-133x(87)90004-2 · Cited by 316
Self-citationXu, M., Koeltzow, T. E., Santiago, G. T., Moratalla, R., Cooper, D. C., Hu, X.-T., White, N. M., Graybiel, A. M., White, F. J., & Tonegawa, S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80965-4 · Cited by 315
Chromosome 1 loci in Finnish schizophrenia families
Ekelund, J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.15.1611 · Cited by 312
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.738 · Cited by 312
PCP: from pharmacology to modelling schizophrenia
Morris, B. J., Cochran, S. M., & Pratt, J. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.008 · Cited by 308
Owen, M. J., Craddock, N., & O'Donovan, M. C. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.06.011 · Cited by 307
Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity
Ingi, T., Krumins, A. M., Chidiac, P., Brothers, G. M., Chung, S., Snow, B. E., Barnes, C. A., Lanahan, A. A., Siderovski, D. P., Ross, E. M., et al. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07178.1998 · Cited by 298
Vezina, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02411.1996 · Cited by 283
Schizophrenia: More dopamine, more D 2 receptors
Seeman, P., & Kapur, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7673 · Cited by 279
Self-citationSegregation at three loci explains familial and population risk in Hirschsprung disease
Gabriel, S. B., Salomon, R., Pelet, A., Angrist, M., Amiel, J., Fornage, M., Attié-Bitach, T., Olson, J. M., Hofstra, R., Buys, C., et al. (2002) · Nature Genetics · doi:10.1038/ng868 · Cited by 275
Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses
Lieberman, J. A., Kinon, B. J., & Loebel, A. D. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.97 · Cited by 274
Holzman, P. S. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800310049006 · Cited by 269
Paterlini, M., Zakharenko, S. S., Lai, W.-S., Qin, J., Zhang, H., Mukai, J., Westphal, K. G. C., Olivier, B., Sulzer, D., Pavlidis, P., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1562 · Cited by 265
RGS9 Modulates Dopamine Signaling in the Basal Ganglia
Rahman, Z., Schwarz, J., Gold, S. J., Zachariou, V., Wein, M. N., Choi, K.-H., Kovoor, A., Chen, C.-K., DiLeone, R. J., Schwarz, S. C., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00321-0 · Cited by 265
Self-citationDeroche, V, Marinelli, M., Maccari, S., Le Moal, M., Simon, H., & Piazza, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07181.1995 · Cited by 262
BDNF gene is a risk factor for schizophrenia in a Scottish population
Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., Sinclair, M., Crombie, C., Walker, N., & St Clair, D. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001575 · Cited by 262
Phenotype of schizophrenia: a review and formulation
Tamminga, C. A., & Holcomb, H. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001563 · Cited by 262
RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors
Xu, X., Zeng, W., Popov, S., Berman, D. M., Davignon, I., Yu, K., Yowe, D., Offermanns, S., Muallem, S., & Wilkie, T. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3549 · Cited by 253
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Self-citationEssential role for RGS9 in opiate action
Zachariou, V., Georgescu, D., Sanchez, N., Rahman, Z., DiLeone, R., Berton, O., Neve, R. L., Sim-Selley, L. J., Selley, D. E., Gold, S. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232594100 · Cited by 250
Cocaine-Induced Psychosis: (324222004-013)
Brady, K. T., Lydiard, R. B., Malcolm, R., & Ballenger, J. C. (1992) · PsycEXTRA Dataset · doi:10.1037/e324222004-013 · Cited by 243
Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia
Ludewig, K., Geyer, M. A., & Vollenweider, F. X. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01925-x · Cited by 240
Seeman, P., & Tallerico, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.876 · Cited by 237
Self-citationMartin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237
Pippig, S., Andexinger, S., Daniel, K., Puzicha, M., Caron, M. G., Lefkowitz, R. J., & Lohse, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53678-4 · Cited by 231
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
Gainetdinov, R. R., Bohn, L. M., Sotnikova, T. D., Cyr, M., Laakso, A., Macrae, A. D., Torres, G. E., Kim, K.-M., Lefkowitz, R. J., Caron, M. G., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00192-2 · Cited by 230
Wilson, A. A., McCormick, P., Kapur, S., Willeit, M., Garcia, A., Hussey, D., Houle, S., Seeman, P., & Ginovart, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050155n · Cited by 226
Self-citationNeuroleptic-induced supersensitivity psychosis
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1409 · Cited by 224
NEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALS
Sibley, D. R. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.313 · Cited by 222
Depoortère, R., Dargazanli, G., Estenne-Bouhtou, G., Coste, A., Lanneau, C., Desvignes, C., Poncelet, M., Heaulme, M., Santucci, V., Decobert, M., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300772 · Cited by 220
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis
Tuominen, H. J., Tiihonen, J., & Wahlbeck, K. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.05.005 · Cited by 209
Interaction with Neuronal Calcium Sensor NCS-1 Mediates Desensitization of the D2 Dopamine Receptor
Kabbani, N., Negyessy, L., Lin, R., Goldman-Rakic, P., & Levenson, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08476.2002 · Cited by 207
McNeil, T. F., Cantor-Graae, E., & Weinberger, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.203 · Cited by 206
Koh, P. O., Undie, A. S., Kabbani, N., Levenson, R., Goldman-Rakic, P. S., & Lidow, M. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232693499 · Cited by 204
Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
Seeman, P., Ko, F., & Tallerico, T. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001682 · Cited by 200 · cited 19×
“As reviewed below, behavioral dopamine supersensitivity is invariably associated with an elevation in D2High, that is, an elevation in the proportion of dopamine D2 receptors in the state of high affinity for dopamine (Seeman et al., 2005a).”
BackgroundMethodInfluentialSelf-citationR9AP, a membrane anchor for the photoreceptor GTPase accelerating protein, RGS9-1
Hu, G., & Wensel, T. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152094799 · Cited by 192
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman, P., Niznik, H. B., Guan, H. C., Booth, G., & Ulpian, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10156 · Cited by 191
Self-citationLipska, B. K., & Weinberger, D. R. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90026-7 · Cited by 189
Flores, G., Barbeau, D., Quirion, R., & Srivastava, L. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02020.1996 · Cited by 187
Self-citationHouchi, H., Babovic, D., Pierrefiche, O., Ledent, C., Daoust, M., & Naassila, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300568 · Cited by 182
Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice
Huotari, M., Gogos, J. A., Karayiorgou, M., Koponen, O., Forsberg, M., Raasmaja, A., Hyttinen, J., & Männistö, P. T. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01856.x · Cited by 180
Strakowski, S. M., Sax, K. W., Setters, M. J., & Keck, P. E. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00497-1 · Cited by 179
STRUCTURE OF MEMBRANE HOLES IN OSMOTIC AND SAPONIN HEMOLYSIS
Seeman, P., Cheng, D., & Iles, G. H. (1973) · The Journal of Cell Biology · doi:10.1083/jcb.56.2.519 · Cited by 179
Self-citationDefects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation
Nishiguchi, K. M., Sandberg, M. A., Kooijman, A. C., Martemyanov, K. A., Pott, J. W. R., Hagstrom, S. A., Arshavsky, V. Y., Berson, E. L., & Dryja, T. P. (2004) · Nature · doi:10.1038/nature02170 · Cited by 178
Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174
Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
Wreggett, K. A., & Wells, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22488 · Cited by 174
Le Pen, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00383-9 · Cited by 173
GEORGE, S. R., WATANABE, M., PAOLO, T. D., FALARDEAU, P., LABRIE, F., & SEEMAN, P. (1985) · Endocrinology · doi:10.1210/endo-117-2-690 · Cited by 171
Self-citationKovoor, A., Seyffarth, P., Ebert, J., Barghshoon, S., Chen, C.-K., Schwarz, S., Axelrod, J. D., Cheyette, B. N. R., Simon, M. I., Lester, H. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2840-04.2005 · Cited by 171
Self-citationALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine Transporter
Atkinson, B. N., Bell, S. C., De Vivo, M., Kowalski, L. R., Lechner, S. M., Ognyanov, V. I., Tham, C.-S., Tsai, C., Jia, J., Ashton, D., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1414 · Cited by 169
Seeman, P., Ulpian, C., Wreggett, K. A., & Wells, J. W. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06700.x · Cited by 169
Self-citationBehavioral characterization of dopamine D₅ receptor null mutant mice.
Holmes, A., Hollon, T. R., Gleason, T. C., Liu, Z., Dreiling, J., Sibley, D. R., & Crawley, J. N. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.5.1129 · Cited by 168
Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine signaling
Bergson, C., Levenson, R., Goldman-Rakic, P. S., & Lidow, M. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00232-3 · Cited by 164
Increased Caudate Dopamine D2 Receptor Availability as a Genetic Marker for Schizophrenia
Hirvonen, J., van Erp, T. G. M., Huttunen, J., Aalto, S., Någren, K., Huttunen, M., Lönnqvist, J., Kaprio, J., Hietala, J., & Cannon, T. D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.371 · Cited by 162
Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.
Vonvoigtlander, P. F., Losey, E. G., & Triezenberg, H. J. (1975) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30124-2 · Cited by 160
Egan, M. F., & Weinberger, D. R. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80092-x · Cited by 158
Boksa, P., & El-Khodor, B. F. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00012-5 · Cited by 157
Self-citationDefective Motor Behavior and Neural Gene Expression in RIIβ-Protein Kinase A Mutant Mice
Brandon, E. P., Logue, S. F., Adams, M. R., Qi, M., Sullivan, S. P., Matsumoto, A. M., Dorsa, D. M., Wehner, J. M., McKnight, G. S., & Idzerda, R. L. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03639.1998 · Cited by 154
Self-citationAssessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors
Brody, S. A., Dulawa, S. C., Conquet, F., & Geyer, M. A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001404 · Cited by 153
James, R., Adams, R. R., CHRISTIE, S., Buchanan, S. R., Porteous, D. J., & Millar, J. K. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.013 · Cited by 150
Xu, M., Guo, Y. H., Vorhees, C. V., & Zhang, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02258-1 · Cited by 149
Nordström, A., Farde, L., Eriksson, L. I., & Halldin, C. (1995) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(95)02732-d · Cited by 149
Morishima, Y., Miyakawa, T., Furuyashiki, T., Tanaka, Y., Mizuma, H., & Nakanishi, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500914102 · Cited by 148
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Schlüter, O. M., Fornai, F., Alessandri, M., TAKAMORI, S., Geppert, M., Jahn, R., & Südhof, T. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00036-8 · Cited by 147
Dopamine-Deficient Mice Are Hypersensitive to Dopamine Receptor Agonists
Kim, D. S., Szczypka, M. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04405.2000 · Cited by 146
Mackeprang, T., Kristiansen, K. T., & Glenthoj, B. Y. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01409-9 · Cited by 144
The Presynaptic Active Zone Protein RIM1α Is Critical for Normal Learning and Memory
Powell, C. M., Schoch, S., Monteggia, L., Barrot, M., Matos, M. F., Feldmann, N., Südhof, T. C., & Nestler, E. J. (2004) · Neuron · doi:10.1016/s0896-6273(04)00146-1 · Cited by 143
NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder
Mueller, H. T., & Meador‐Woodruff, J. H. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.016 · Cited by 139
High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO
Willeit, M., Ginovart, N., Kapur, S., Houle, S., Hussey, D. F., Seeman, P. M., & Wilson, A. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.017 · Cited by 136
Self-citationDopamine D2 receptor binding sites for agonists. A tetrahedral model.
Seeman, P. M., Watanabe, M., Grigoriadis, D. E., Tedesco, J. L., George, S. R., Svensson, U. S. H., Nilsson, J., & Neumeyer, J. L. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14176-x · Cited by 135
Self-citationSex differences in prepulse inhibition deficits in chronic schizophrenia
Kumari, V., Aasen, I., & Sharma, T. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.010 · Cited by 134
Stimulant-induced psychosis and schizophrenia: The role of sensitization
Ujike, H. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0024-7 · Cited by 134
Holmes, A., Lachowicz, J. E., & Sibley, D. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.034 · Cited by 133
The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia
Dubertret, C., Gouya, L., Hanoun, N., Deybach, J., Adès, J., Hamon, M., & Gorwood, P. A. P. M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00220-2 · Cited by 132
Support for RGS4 as a susceptibility gene for schizophrenia
Williams, N. M., Preece, A. C., Spurlock, G., Norton, N., Williams, H. J., McCreadie, R. G., Buckland, P. R., Sharkey, V., Chowdari, K. V., Zammit, S., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.002 · Cited by 132
Kathmann, N., Hochrein, A., Uwer, R., & Bondy, B. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.696 · Cited by 132
Szechtman, H., Eckert, M. J., Tse, W. S., Boersma, J. T., Bonura, C. A., McClelland, J. Z., Culver, K. E., & Eilam, D. (2001) · BMC Neuroscience · doi:10.1186/1471-2202-2-4 · Cited by 129
Self-citationSchank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129
Self-citationSeeman, P. M., Tallerico, T., & Ko, F. (2003) · Synapse · doi:10.1002/syn.10232 · Cited by 128
Self-citationJaskiw, G. E., Karoum, F., Freed, W. J., Phillips, I., Kleinman, J. E., & Weinberger, D. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90138-2 · Cited by 127
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia
Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001321 · Cited by 125
Severe cases of neuroleptic-induced supersensitivity psychosis
Chouinard, G. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90050-2 · Cited by 123
McDonald, W. M., Sibley, D. R., Kilpatrick, B. F., & Caron, M. G. (1984) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(84)90037-6 · Cited by 122
Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
Steiner, H., Bonner, T. I., Zimmer, A. M., Kitai, S. T., & Zimmer, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5786 · Cited by 119
Wong, D. F., Pearlson, G. D., Tune, L. E., Young, L. T., Meltzer, C. C., Dannals, R. F., Ravert, H. T., Reith, J., Kuhar, M. J., & Gjedde, A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199703000-00010 · Cited by 118
Chen, J.-F., Beilstein, M. A., Xu, Y., Turner, T. J., Moratalla, R., Standaert, D. G., Aloyo, V. J., Fink, J. S., & Schwarzschild, M. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00604-1 · Cited by 117
Self-citationFlores, G., Wood, G. K., Liang, J.-J., Quirion, R., & Srivastava, L. K. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07366.1996 · Cited by 116
Self-citationSensitization and habituation of the acoustic startle reflex in patients with schizophrenia
Meincke, U., Light, G. A., Geyer, M. A., BRAFF, D. L., & Gouzoulis‐Mayfrank, E. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.01.003 · Cited by 116
Association study of schizophrenia with polymorphisms at six candidate genes
Virgos, C., Martorell, L., Valero, J., Civeira, F., Joven, J., Labad, A., Vilella, E., & Figuera, L. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00106-7 · Cited by 115
Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis.
Seeman, P. M. (1974) · PubMed · Cited by 115
Self-citationProlonged fear responses in mice lacking dopamine D1 receptor
El-Ghundi, M., O’Dowd, B. F., & George, S. R. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03234-0 · Cited by 113
Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated
Ögren, S. O., & Goldstein, M. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380103 · Cited by 111
Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing Medication
Prien, R. F., Cole, J. O., & Belkin§, N. F. (1969) · The British Journal of Psychiatry · doi:10.1192/bjp.115.523.679 · Cited by 111
Ralph, R. J., Masten, V. L., Otero-Corchón, V., Low, M. J., & Geyer, M. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09604.2002 · Cited by 111
Taymans, J., Leysen, J. E., & Langlois, X. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01610.x · Cited by 110
Whither Goest the RGS Proteins?
Siderovski, D. P., Strockbine, B., & Behe, C. I. (1999) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239991209273 · Cited by 110
Generation and Characterization of Rgs4 Mutant Mice
Grillet, N., Pattyn, A., Contet, C., Kieffer, B. L., Goridis, C., & Brunet, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4221-4228.2005 · Cited by 110
Regulators of G Protein Signaling: Rapid Changes in mRNA Abundance in Response to Amphetamine
Burchett, S. A., Volk, M. L., Bannon, M. J., & Granneman, J. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052216.x · Cited by 109
Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists
Chartoff, E. H., Heusner, C. L., & Palmiter, R. D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300678 · Cited by 108
Maziade, M., Roy, M.-A., Rouillard, E., Bissonnette, L., Fournier, J.-P., Roy, A., Garneau, Y., Montgrain, N., Potvin, A., Cliche, D., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000915 · Cited by 108
Tenn, C. C., Fletcher, P. J., & Kapur, S. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00009-4 · Cited by 106
Jakob, H., & Beckmann, H. (1994) · Journal of Neural Transmission · doi:10.1007/bf01277013 · Cited by 106
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105
The case against antipsychotic drugs: a 50-year record of doing more harm than good
Whitaker, R. B. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00293-7 · Cited by 104
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
Weinshenker, D., Miller, N. S., Blizinsky, K. D., Laughlin, M. L., & Palmiter, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519999 · Cited by 103
Self-citationMesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice
Smith, D. G., Tzavara, E. T., Shaw, J., Luecke, S., Wade, M., Davis, R., Salhoff, C., Nomikos, G. G., & Gehlert, D. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4079-04.2005 · Cited by 103
One Year After Discharge: Community Adjustment of Schizophrenic Patients
Schooler, N. R., Goldberg, S. C., Boothe, H., & Cole, J. O. (1967) · American Journal of Psychiatry · doi:10.1176/ajp.123.8.986 · Cited by 103
Vekovischeva, O. Y., Zamanillo, D., Echenko, O., Seppälä, T., Uusi‐Oukari, M., Honkanen, A., Seeburg, P. H., Sprengel, R., & Korpi, E. R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04451.2001 · Cited by 103
Oranje, B., van Oel, C. J., Wied, C. C. G., Verbaten, M. N., & Kahn, R. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00005 · Cited by 103
Thiselton, D. L., Webb, B. T., Neale, B. M., Ribble, R., O’Neill, F. A., Walsh, D., Riley, B. P., & Kendler, K. S. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001530 · Cited by 102
An Update of Fast-Off Dopamine D2 Atypical Antipsychotics
Seeman, P. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1984-a · Cited by 101
Self-citationUjike, H., Akiyama, K., & Otsuki, S. (1990) · Psychopharmacology · doi:10.1007/bf02247125 · Cited by 101
A Crucial Role for Forebrain Adenosine A2A Receptors in Amphetamine Sensitization
Bastia, E., Xu, Y., Scibelli, A. C., Day, Y., Linden, J. M., Chen, J., & Schwarzschild, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300630 · Cited by 100
Self-citationWan, R.-Q., Giovanni, A., Kafka, S. H., & Corbett, R. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00251-0 · Cited by 100
Tune, L. E., Wong, D. F., Pearlson, G. D., Strauss, M. E., YOUNG, T. J. K., Shaya, E. K., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sapp, J., et al. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90063-m · Cited by 100
Cabrera-Vera, T. M., Hernandez, S., Earls, L. R., Medkova, M., Sundgren‐Andersson, A. K., Surmeier, D. J., & Hamm, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407416101 · Cited by 100
The genetics of schizophrenia: glutamate not dopamine?
Collier, D. A., & Li, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.105 · Cited by 99
Cited by
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Fone, K. C. F., & Porkess, M. V. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.003 · Cited by 864
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Glutamate and dopamine in schizophrenia: An update for the 21 st century
Howes, O., McCutcheon, R., & Stone, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114563634 · Cited by 702
Metadata
- Authors
- Seeman, P., Schwarz, J., Chen, J.-F., Szechtman, H., Perreault, M., McKnight, G. S., Roder, J. C., Quirion, R., Boksa, P., Srivastava, L. K., Yanai, K., Weinshenker, D., & Sumiyoshi, T.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2006
- Volume
- 60
- Issue
- 4
- Pages
- 319-346
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1992991774
- Cited by
- 330
- References
- 323
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.